ACHV
Price:
$4.29
Market Cap:
$147.53M
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
1995-10-12
Stock Exchange
NASDAQ
Ticker
ACHV
According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 147.83M. This represents a change of 22.18% compared to the average of 121.00M of the last 4 quarters.
The mean historical Enterprise Value of Achieve Life Sciences, Inc. over the last ten years is 10.19M. The current 147.83M Enterprise Value has changed 144.93% with respect to the historical average. Over the past ten years (40 quarters), ACHV's Enterprise Value was at its highest in in the June 2024 quarter at 166.93M. The Enterprise Value was at its lowest in in the December 2019 quarter at -10576844.60.
Average
10.19M
Median
507.40K
Minimum
-13660837.10
Maximum
82.87M
Discovering the peaks and valleys of Achieve Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 376.84%
Maximum Annual Enterprise Value = 82.87M
Minimum Annual Increase = -864.57%
Minimum Annual Enterprise Value = -13660837.10
Year | Enterprise Value | Change |
---|---|---|
2023 | 82.87M | 376.84% |
2022 | 17.38M | -14.06% |
2021 | 20.22M | -248.04% |
2020 | -13660837.10 | 14.49% |
2019 | -11931408.00 | 127.50% |
2018 | -5244658.00 | -549.22% |
2017 | 1.17M | -864.57% |
2016 | -152700.00 | -93.93% |
2015 | -2515130.00 | -118.23% |
2014 | 13.80M | -87.74% |
The current Enterprise Value of Achieve Life Sciences, Inc. (ACHV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
40.16M
5-year avg
18.98M
10-year avg
10.19M
Achieve Life Sciences, Inc.’s Enterprise Value is less than VectivBio Holding AG (848.58M), less than Icosavax, Inc. (713.87M), less than Apellis Pharmaceuticals, Inc. (3.90B), less than iTeos Therapeutics, Inc. (185.75M), less than TScan Therapeutics, Inc. (184.60M), less than Day One Biopharmaceuticals, Inc. (963.46M), greater than Acumen Pharmaceuticals, Inc. (139.19M), greater than X4 Pharmaceuticals, Inc. (38.44M), less than Inozyme Pharma, Inc. (202.73M), greater than Immix Biopharma, Inc. (30.53M), greater than CNS Pharmaceuticals, Inc. (209.41K), greater than Hepion Pharmaceuticals, Inc. (5.35M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than AVROBIO, Inc. (-85302404.00), greater than NextCure, Inc. (11.01M), greater than CytomX Therapeutics, Inc. (39.67M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (-8426888.00), greater than Assembly Biosciences, Inc. (68.59M), greater than Bolt Biotherapeutics, Inc. (30.96M), less than Coherus BioSciences, Inc. (259.52M), less than Gracell Biotechnologies Inc. (5.61B),
Company | Enterprise Value | Market cap |
---|---|---|
848.58M | $1.06B | |
713.87M | $769.04M | |
3.90B | $3.83B | |
185.75M | $303.96M | |
184.60M | $227.36M | |
963.46M | $1.38B | |
139.19M | $142.39M | |
38.44M | $57.64M | |
202.73M | $180.51M | |
30.53M | $49.14M | |
209.41K | $7.15M | |
5.35M | $4.62M | |
2.82M | $28.28M | |
-85302404.00 | $5.24M | |
11.01M | $33.33M | |
39.67M | $69.65M | |
-6333315.00 | $8.20M | |
-8426888.00 | $63.24M | |
68.59M | $95.60M | |
30.96M | $22.14M | |
259.52M | $125.58M | |
5.61B | $989.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Achieve Life Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Achieve Life Sciences, Inc. (ACHV)?
What is the 3-year average Enterprise Value for Achieve Life Sciences, Inc. (ACHV)?
What is the 5-year average Enterprise Value for Achieve Life Sciences, Inc. (ACHV)?
How does the current Enterprise Value for Achieve Life Sciences, Inc. (ACHV) compare to its historical average?